• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Eaton Vance Tax Advantaged Dividend Inc

Eaton Vance Tax Advantaged Dividend Inc

  1. All
  2. 3rd Party
  1. Evotec and MaRS Innovation Establish Strategic Partnership to Launch Fibrocor Therapeutics

    Evotec and MaRS Innovation Establish Strategic Partnership to Launch Fibrocor Therapeutics

  2. Haplogen's Novel Antiviral Target Partnered with Evotec Published in 'Nature'

    Haplogen's Novel Antiviral Target Partnered with Evotec Published in 'Nature'

  3. Evotec and Eternygen to Develop Novel Metabolic Disease Therapy

    Evotec and Eternygen to Develop Novel Metabolic Disease Therapy

  4. Evotec to Attend Three Upcoming Investor Conferences

    Evotec to Attend Three Upcoming Investor Conferences

  5. Some CEFs Are Getting a One-Time Boost to NAV

    The potential for rising rates casts ARPS in a new light, and falling commodity prices continue to pressure MLP closed-end funds.

  6. Commodities CEFs Tank in September

    The Bond King's departure had a small impact on CEF performance compared with the onslaught in the commodities market.

  7. Lower Your Tax Bill With Equity Tax-Advantaged Funds

    Investors should consider these dividend-seeking equity funds for their tax advantages. 

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.